Patient Guide: A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD).

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04912869
Status: ACTIVE_NOT_RECRUITING
Condition: Anemia, Sickle Cell
Phase: PHASE1

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Atlanta, Georgia
  • • New York, New York
  • • Salvador, Bahia
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD). - Join Clinical Trial NCTNCT04912869

How to Join This Clinical Trial - NCTNCT04912869

Learn how to participate in this PHASE1 trial studying an investigational therapy for Anemia, Sickle Cell. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Anemia, Sickle Cell. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Anemia, Sickle Cell
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04912869 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Atlanta, Georgia 30329 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10029 - United States

Status: Contact for availability

Clinical Research Site

Salvador, Bahia 41253-190 - Brazil

Status: Contact for availability

Clinical Research Site

Porto Alegre, Rio Grande Do Sul - Brazil

Status: Contact for availability

Clinical Research Site

Créteil, 64010 - France

Status: Contact for availability

Clinical Research Site

Verona, Veneto 37134 - Italy

Status: Contact for availability

Clinical Research Site

Eldoret, 30100 - Kenya

Status: Contact for availability

Clinical Research Site

Nairobi, - Kenya

Status: Contact for availability

Clinical Research Site

Beirut, 1107 2020 - Lebanon

Status: Contact for availability

Clinical Research Site

Tripoli, - Lebanon

Status: Contact for availability

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Anemia, Sickle Cell:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships